IN MEMORIAM

Emmanuel van der Schueren

Sir Michael Peckham

JCO Feb 1 1999: 437. [Full Text] [PDF]

EDITORIALS

Acute Lymphoblastic Leukemia in Infants

Ching-Hon Pui and William E. Evans

JCO Feb 1 1999: 438. [Full Text] [PDF]

Neoadjuvant Chemotherapy, Locally Advanced Breast Cancer, and Quality of Life

Kelly M. McMasters and Kelly K. Hunt

JCO Feb 1 1999: 441. [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	Treatment Outcome and Prognostic Factors for Infants With Acute Lymphoblastic Leukemia Treated on Two Consecutive Trials of the Children's Cancer Group
	Gregory H. Reaman, Richard Sposto, Martha G. Sensel, Beverly J. Lange, James H. Feusner, Nyla A. Heerema, Marcia Leonard, Emiko J. Holmes, Harland N. Sather, Thomas W. Pendergrass, Helen S. Johnstone, Richard T. O'Brien, Peter G. Steinherz, Paul M. Zeltzer, Paul S. Gaynon, Michael E. Trigg, and Fatih M. Uckun
	JCO Feb 1 1999: 445. [Abstract] [Full Text] [PDF]
	Treatment of Localized Primary Non-Hodgkin's Lymphoma of Bone in Children: A Pediatric Oncology Group Study
	Kaveri Suryanarayan, Jonathan J. Shuster, Sarah S. Donaldson, Robert E. Hutchison, Sharon B. Murphy, and Michael P. Link
	JCO Feb 1 1999: 456. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
	Henry M. Kuerer, Lisa A. Newman, Terry L. Smith, Fred C. Ames, Kelly K. Hunt, Kapil Dhingra, Richard L. Theriault, Gurpreet Singh, Susan M. Binkley, Nour Sneige, Thomas A. Buchholz, Merrick I. Ross, Marsha D. McNeese, Aman U. Buzdar, Gabriel N. Hortobagyi, and S. Eva Singletary
	JCO Feb 1 1999: 460. [Abstract] [Full Text] [PDF]
	Comparison of Mitotic Index, In Vitro Bromodeoxyuridine Labeling, and MIB-1 Assays to Quantitate Proliferation in Breast Cancer
	Ann D. Thor, Shuqing Liu, Dan H. Moore II, and Susan M. Edgerton
	JCO Feb 1 1999: 470. [Abstract] [Full Text] [PDF]
	Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
	Anthony W. Tolcher, Steven Sugarman, Karen A. Gelmon, Roger Cohen, Mansoor Saleh, Claudine Isaacs, Leslie Young, Diane Healey, Nicole Onetto, and William Slichenmyer
	JCO Feb 1 1999: 478. [Abstract] [Full Text] [PDF]
	Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
	Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar, Patricia Mucci LoRusso, Irene Kuter, Charles Vogel, Bruno Osterwalder, Hans-Ulrich Burger, Cheryl Stoner Brown, and Tom Griffin
	JCO Feb 1 1999: 485. [Abstract] [Full Text] [PDF]
	Benefits and Costs of Screening Ashkenazi Jewish Women for BRCA1 and BRCA2
	Victor R. Grann, William Whang, Judith S. Jacobson, Daniel F. Heitjan, Karen H. Antman, and Alfred I. Neugut
	JCO Feb 1 1999: 494. [Abstract] [Full Text] [PDF]

GYNECOLOGIC CANCER
	Comparison of Standard and CA-125 Response Criteria in Patients With Epithelial Ovarian Cancer Treated With Platinum or Paclitaxel
	John A. Bridgewater, Ann E. Nelstrop, Gordon J.S. Rustin, Martin E. Gore, William P. McGuire, and William J. Hoskins
	JCO Feb 1 1999: 501. [Abstract] [Full Text] [PDF]

GENITOURINARY CANCER
	Phase II Trial of Gemcitabine in Refractory Germ Cell Tumors
	Lawrence H. Einhorn, Michael J. Stender, and Stephen D. Williams
	JCO Feb 1 1999: 509. [Abstract] [Full Text] [PDF]
	Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer
	C. Bokemeyer, A. Gerl, P. Schöffski, A. Harstrick, N. Niederle, J. Beyer, J. Casper, H.J. Schmoll, and L. Kanz
	JCO Feb 1 1999: 512. [Abstract] [Full Text] [PDF]
	Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer
	Michael J. Zelefsky, Kent E. Wallner, C. Clifton Ling, Adam Raben, Timothy Hollister, Theresa Wolfe, Alison Grann, Paul Gaudin, Zvi Fuks, and Steven A. Leibel
	JCO Feb 1 1999: 517. [Abstract] [Full Text] [PDF]
	Sarcomatoid Renal Cell Carcinoma: Biologic Behavior, Prognosis, and Response to Combined Surgical Resection and Immunotherapy
	Thomas Cangiano, Joseph Liao, John Naitoh, Frederick Dorey, Robert Figlin, and Arie Belldegrun
	JCO Feb 1 1999: 523. [Abstract] [Full Text] [PDF]
	Autoimmunity Resulting From Cytokine Treatment Predicts Long-Term Survival in Patients With Metastatic Renal Cell Cancer
	Anke Franzke, Dietrich Peest, Michael Probst-Kepper, Jan Buer, Gabriele I. Kirchner, Georg Brabant, Hartmut Kirchner, Arnold Ganser, and Jens Atzpodien
	JCO Feb 1 1999: 529. [Abstract] [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	Autotransplants for Hodgkin's Disease in Patients Never Achieving Remission: A Report From the Autologous Blood and Marrow Transplant Registry
	By Hillard M. Lazarus, Philip A. Rowlings, Mei-Jie Zhang, Julie M. Vose, James O. Armitage, Philip J. Bierman, James L. Gajewski, Robert Peter Gale, Arm Keating, John P. Klein, Carole B. Miller, Gordon L. Phillips, Donna E. Reece, Kathleen A. Sobocinski, Koen van Besien, and Mary M. Horowitz
	JCO Feb 1 1999: 534. [Abstract] [Full Text] [PDF]
	Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma
	James M. Foran, Ama Z.S. Rohatiner, Bertr Coiffier, Tiziano Barbui, Stephen A. Johnson, Wolfgang Hiddemann, John A. Radford, Andrew J. Norton, Susan M. Tollerfield, Martin P. Wilson, and T. Andrew Lister
	JCO Feb 1 1999: 546. [Abstract] [Full Text] [PDF]
	Value of Combined Approach With Thallium-201 Single-Photon Emission Computed Tomography and Epstein-Barr Virus DNA Polymerase Chain Reaction in CSF for the Diagnosis of AIDS-Related Primary CNS Lymphoma
	A. Antinori, G. De Rossi, A. Ammassari, A. Cingolani, R. Murri, D. Di Giuda, A. De Luca, F. Pierconti, T. Tartaglione, M. Scerrati, L. M. Larocca, and L. Ortona
	JCO Feb 1 1999: 554. [Abstract] [Full Text] [PDF]
	Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion
	Laurie H. Sehn, Edwin P. Alyea, Edie Weller, Christine Canning, Stephanie Lee, Jerome Ritz, Joseph H. Antin, and Robert J. Soiffer
	JCO Feb 1 1999: 561. [Abstract] [Full Text] [PDF]
	Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins
	Malcolm A. Smith, Lawrence Rubinstein, James R. Anderson, Diane Arthur, Paul J. Catalano, Boris Freidlin, Ruth Heyn, Anita Khayat, Mark Krailo, Vita J. Land, James Miser, Jonathan Shuster, and Don Vena
	JCO Feb 1 1999: 569. [Abstract] [Full Text] [PDF]

GASTROINTESTINAL CANCER
	K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance
	Antoni Castells, Pere Puig, Josefina Móra, Jaume Boadas, Loreto Boix, Eulàlia Urgell, Manel Solé, Gabriel Capellà, Fèlix Lluís, Laureano Fernández-Cruz, Salvador Navarro, and Antoni Farré
	JCO Feb 1 1999: 578. [Abstract] [Full Text] [PDF]
	Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer
	Manuel Hidalgo, Daniel Castellano, Luis Paz-Ares, Cristina Gravalos, Maite Diaz-Puente, Ricardo Hitt, Silvia Alonso, and Hernan Cortes-Funes
	JCO Feb 1 1999: 585. [Abstract] [Full Text] [PDF]
	Prognostic Value of p53 Genetic Changes in Colorectal Cancer
	Ulf Kressner, Mats Inganäs, Sara Byding, Ingrid Blikstad, Lars Påhlman, Bengt Glimelius, and Gudrun Lindmark
	JCO Feb 1 1999: 593. [Abstract] [Full Text] [PDF]
	Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
	Joseph Rubin, Jaffer Ajani, William Schirmer, Alan P. Venook, Ronald Bukowski, Rodney Pommier, Leonard Saltz, Paresh Dandona, and Lowell Anthony
	JCO Feb 1 1999: 600. [Abstract] [Full Text] [PDF]
	Role of Transforming Growth Factor-ß1 in Invasion and Metastasis in Gastric Carcinoma
	Yoshihiko Maehara, Yoshihiro Kakeji, Akira Kabashima, Yasunori Emi, Akihiro Watanabe, Kohei Akazawa, Hideo Baba, Shunji Kohnoe, and Keizo Sugimachi
	JCO Feb 1 1999: 607. [Abstract] [Full Text] [PDF]
	Prospective Study of the Clinical Course, Prognostic Factors, Causes of Death, and Survival in Patients With Long-Standing Zollinger-Ellison Syndrome
	Fang Yu, David J. Venzon, Jose Serrano, Stephan U. Goebel, John L. Doppman, Fathia Gibril, and Robert T. Jensen
	JCO Feb 1 1999: 615. [Abstract] [Full Text] [PDF]

HEAD AND NECK CANCER
	Preradiotherapy Computed Tomography as a Predictor of Local Control in Supraglottic Carcinoma
	Anthony A. Mancuso, Suresh K. Mukherji, Ilona Schmalfuss, William Mendenhall, James Parsons, Frank Pameijer, Robert Hermans, and Paul Kubilis
	JCO Feb 1 1999: 631. [Abstract] [Full Text] [PDF]
	Radiation Therapy With Concomitant Hydroxyurea and Fluorouracil in Stage II and III Head and Neck Cancer
	Daniel J. Haraf, Merrill Kies, Alfred W. Rademaker, Kerstin Stenson, Bharat Mittal, Harold Pelzer, Barry Wenig, Mary Ellyn Witt, Laura Sulzen, Ralph R. Weichselbaum, and Everett E. Vokes
	JCO Feb 1 1999: 638. [Abstract] [Full Text] [PDF]

BRAIN TUMORS
	Procarbazine and High-Dose Tamoxifen as a Second-Line Regimen in Recurrent High-Grade Gliomas: A Phase II Study
	Alba A. Brandes, Mario Ermani, Sergio Turazzi, Elvira Scelzi, Franco Berti, Pietro Amistà, Antonino Rotilio, Claudio Licata, and Mario V. Fiorentino
	JCO Feb 1 1999: 645. [Abstract] [Full Text] [PDF]

MELANOMA
	Combination of Chemotherapy With Interleukin-2 and Interferon Alfa for the Treatment of Metastatic Melanoma
	Jon M. Richards, Danielle Gale, Nilesh Mehta, and Timothy Lestingi
	JCO Feb 1 1999: 651. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
	Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd, Scott Z. Fields, J.P. Kleisbauer, Nick G. Chrysson, David J. Stewart, Peter I. Clark, Martin C. Palmer, Alain Depierre, James Carmichael, Jacqueline B. Krebs, Graham Ross, Stephen R. Lane, and Richard Gralla
	JCO Feb 1 1999: 658. [Abstract] [Full Text] [PDF]
	Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer
	Stephen L. Graziano, Gary P. Gamble, Nancy B. Newman, Lynn Z. Abbott, Michelle Rooney, Sulagna Mookherjee, Melissa L. Lamb, Leslie J. Kohman, and Bernard J. Poiesz
	JCO Feb 1 1999: 668. [Abstract] [Full Text] [PDF]
	Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer
	Chandra P. Belani, Christine M. Kearns, Eleanor G. Zuhowski, Kadir Erkmen, Deborah Hiponia, Denise Zacharski, Christine Engstrom, Ramesh K. Ramanathan, Mary Jo Capozzoli, Joseph Aisner, and Merrill J. Egorin
	JCO Feb 1 1999: 676. [Abstract] [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
	Ronald L. Drengler, John G. Kuhn, Larry J. Schaaf, Gladys I. Rodriguez, Miguel A. Villalona-Calero, Lisa A. Hammond, Joseph A. Stephenson, Jr., Stephanie Hodges, Maura A. Kraynak, Brian A. Staton, Gary L. Elfring, Paula K. Locker, Langdon L. Miller, Daniel D. Von Hoff, and Mace L. Rothenberg
	JCO Feb 1 1999: 685. [Abstract] [Full Text] [PDF]
	Phase I Study of Liposomal Vincristine
	K. A. Gelmon, A. Tolcher, A. R. Diab, M. B. Bally, L. Embree, N. Hudon, C. Dedhar, D. Ayers, A. Eisen, B. Melosky, C. Burge, P. Logan, and L. D. Mayer
	JCO Feb 1 1999: 697. [Abstract] [Full Text] [PDF]

SUPPORTIVE CARE AND QUALITY OF LIFE
	Health-Related Quality of Life 1 Year After Allogeneic or Autologous Stem-Cell Transplantation: A Prospective Study
	Marianne J. Hjermstad, Stein A. Evensen, Stein O. Kvaløy, Peter M. Fayers, and Stein Kaasa
	JCO Feb 1 1999: 706. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Cancer Control in Susceptible Groups: Opportunities and Challenges
	Frederick P. Li
	JCO Jan 1 1999: 719. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Two Uncommon Lymphomas

Ch. Jung, M. Gross, U. Kronawitter, S. Danhauser-Riedl, F.-D. Goebel, and D. Schlondorff

JCO Feb 1 1999: 726. [Full Text] [PDF]

Two Uncommon Lymphomas

C. S. Chim, S. K. Ma, C. K. Lam, and R. Liang

JCO Feb 1 1999: 728. [Full Text] [PDF]

CORRESPONDENCE
	Coming Together to Conquer Cancer
	Ellen Stovall and Dean Gesme
	JCO Feb 1 1999: 730. [Full Text] [PDF]
	MOPP Versus ABVD and Low-Dose Versus High-Dose Irradiation in Hodgkin's Disease at Intermediate and Advanced Stages: Analysis of a Meta-Analysis by Clinicians
	Jean Marie Andrieu, Ugur Yilmaz, Pierre Colonna, M. Loeffler, O. Brosteanu, and D. Hasenclever
	JCO Feb 1 1999: 730a. [Full Text] [PDF]
	Chemotherapy of Advanced Non–Small-Cell Lung Cancer: "Those Who Cannot Remember the Past Are Condemned to Repeat It"
	Christian Sauter, Antoinette J. Wozniak, and Giuseppe Giaccone
	JCO Feb 1 1999: 730b. [Full Text] [PDF]
	Risk of Risk-Based Mammography Screening, Ages 40 to 49
	Lawrence W. Bassett, Valerie P. Jackson, Gilda Cardenosa, Daniel B. Kopans, Carl J. D'Orsi, Michael N. Linver, Peter J. Dempsey, Ellen B. Mendelson, D. David Dershaw, Barbara Monsees, Judy M. Destouet, Michael J. Racenstein, W. Philip Evans, III, Edward A. Sickles, Stephen A. Feig, Carol B. Stelling, R. Edward Hendrick, Linda Warren, Mitchell H. Gail, and Barbara K. Rimer
	JCO Feb 1 1999: 730c. [Full Text] [PDF]
	Efficacy of Controlled-Release Oxycodone
	Thomas Comerford and Eduardo Bruera
	JCO Feb 1 1999: 730d. [Full Text] [PDF]
	Wherefore Global Quality-of-Life Assessment?
	Mark R. Somerfield, J. Sloan, and C. Loprinzi
	JCO Feb 1 1999: e730. [Full Text] [PDF]

SPECIAL DEPARTMENTS

ERRATA

Correction for vol. 16, p. 3105

JCO Feb 1 1999: 740. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.